Lithium Energy Limited News - LEL

Acquisition

Eli Lilly and Company Lilly and Applied Molecular Evolution Announce Merger Agreement Eli Lilly and Company (NYSE:LLY) and Applied Molecular...

Antisense Drug Targeting Survivin Inhibits Growth Of Tumors In Animal Models; Data Support Clinical Development

Eli Lilly and Company Asia Martin, 317-276-6987 or Isis Pharmaceuticals, Inc. Karen Lundstedt, 760-603-3880 Eli Lilly and Company and Isis...

After 12 Months, Largest-Ever Real-World Schizophrenia Study Shows Atypical Antipsychotics More Effective Than Typicals with Ran

Eli Lilly and Company Kindra Strupp, +1 317-277-5170 or GCI Group Leslie Berland, +1 212-537-8235 or GCI Group (UK) Sandy Minck, 44 2070 724 134...

Eli Lilly and Company: Long-Term Study Suggests Cymbalta Demonstrates High Tolerability and Safety; One-Year Data Shows High Lik

Eli Lilly and Company David Shaffer (US), 317-651-3710 Jennifer Yoder (Global), 317-652-0912 Cymbalta(TM) (duloxetine HCl)(TM) was safe and well...

Eli Lilly and Company: A Majority of Men With Erectile Dysfunction Chose to Attempt Sexual Intercourse After Four and up to 24 H

Lilly Jane Calloway, 317-651-5870 or ICOS Lacy Fitzpatrick, 425-415-2207 An Independent Clinical Trial Shows That Cialis Was Preferred Over...

Two New Head-to-Head Studies Assess Patient Preference Between Lilly ICOS' Cialis -tadalafil- and Viagra -sildenafil citrate- fo

Lilly Jane Calloway, 317-651-5870 or ICOS Lacy Fitzpatrick, 425-415-2207 Lilly ICOS LLC (NYSE:LLY)(Nasdaq:ICOS). In a recently published study...

Reaching New Heights 'Moving Together Against Breast Cancer'; Lilly, Komen Italia Onlus and Kristin Scott Thomas Address Importa

Eli Lilly and Company Eli Lilly and Company, together with Komen Italia Onlus and Academy award nominee, Kristin Scott Thomas, join international...

Lilly and Harvard Announce New Research and Training Initiative for Multi-Drug Resistant Tuberculosis In Tomsk, Siberia

Lilly U.S. Edward Sagebiel, 317-433-9899 or Lilly Russia Olga Katroukha, 7-095-258-5001 or Harvard/BWH U.S. Christine Baratta, 617-534-1602 or...

Product Launch

Lilly (Eli) & Co First Breakthrough Bone Formation Agent, Lilly's Forsteo, Now Available for the Treatment of Established Osteoporosis in the...

Eli Lilly and Company: Results of Landmark Schizophrenia Study Show Patients Treated with Olanzapine Demonstrated Better Adheren

Eli Lilly and Company Medication Adherence Associated with Improved Long-term Outcomes Patients with schizophrenia treated with olanzapineare...

Eli Lilly and Company: Landmark Schizophrenia Trial Shows Treatment with Olanzapine Results in Less Hospitalization and Signific

Eli Lilly and Company Marni Lemons, 317-433-8990 or GCI Group Regan Reinerth, 312-424-5313 Hospitalization Savings Estimated to Offset Medication...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Lithium Energy Limited (LEL)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

LEL News

Acquisition

Antisense Drug Targeting Survivin Inhibits Growth Of Tumors In Animal Models; Data Support Clinical Development

After 12 Months, Largest-Ever Real-World Schizophrenia Study Shows Atypical Antipsychotics More Effective Than Typicals with Ran

Eli Lilly and Company: Long-Term Study Suggests Cymbalta Demonstrates High Tolerability and Safety; One-Year Data Shows High Lik

Eli Lilly and Company: A Majority of Men With Erectile Dysfunction Chose to Attempt Sexual Intercourse After Four and up to 24 H

Two New Head-to-Head Studies Assess Patient Preference Between Lilly ICOS' Cialis -tadalafil- and Viagra -sildenafil citrate- fo

Reaching New Heights 'Moving Together Against Breast Cancer'; Lilly, Komen Italia Onlus and Kristin Scott Thomas Address Importa

Lilly and Harvard Announce New Research and Training Initiative for Multi-Drug Resistant Tuberculosis In Tomsk, Siberia

Product Launch

Eli Lilly and Company: Results of Landmark Schizophrenia Study Show Patients Treated with Olanzapine Demonstrated Better Adheren

Eli Lilly and Company: Landmark Schizophrenia Trial Shows Treatment with Olanzapine Results in Less Hospitalization and Signific

FDA Informs Lilly of Its Overall Manufacturing Assessment

Research Update

Research Update

Research Update

LEL Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Lithium Energy Limited (LEL) News

Lithium Energy Limited (LEL)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

LEL News

Acquisition

Antisense Drug Targeting Survivin Inhibits Growth Of Tumors In Animal Models; Data Support Clinical Development

After 12 Months, Largest-Ever Real-World Schizophrenia Study Shows Atypical Antipsychotics More Effective Than Typicals with Ran

Eli Lilly and Company: Long-Term Study Suggests Cymbalta Demonstrates High Tolerability and Safety; One-Year Data Shows High Lik

Eli Lilly and Company: A Majority of Men With Erectile Dysfunction Chose to Attempt Sexual Intercourse After Four and up to 24 H

Two New Head-to-Head Studies Assess Patient Preference Between Lilly ICOS' Cialis -tadalafil- and Viagra -sildenafil citrate- fo

Reaching New Heights 'Moving Together Against Breast Cancer'; Lilly, Komen Italia Onlus and Kristin Scott Thomas Address Importa

Lilly and Harvard Announce New Research and Training Initiative for Multi-Drug Resistant Tuberculosis In Tomsk, Siberia

Product Launch

Eli Lilly and Company: Results of Landmark Schizophrenia Study Show Patients Treated with Olanzapine Demonstrated Better Adheren

Eli Lilly and Company: Landmark Schizophrenia Trial Shows Treatment with Olanzapine Results in Less Hospitalization and Signific

FDA Informs Lilly of Its Overall Manufacturing Assessment

Research Update

Research Update

Research Update

LEL Discussion

Your Recent History